[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fpwU6NARX77kUC9DuvEA8cyc27d3wqxLV-33XdkJOUFI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":69,"rows":76},"Medical University of Silesia",[4],107,false,21,6,51280,13,70,[14,17,20,23,25,27,29,31],{"name":15,"count":16},"Temporomandibular Disorder",5,{"name":18,"count":19},"Predictive Value of Tests",4,{"name":21,"count":22},"Endoscopic Sinus Surgery",3,{"name":24,"count":22},"Myofascial Pain",{"name":26,"count":22},"Coronary Artery Calcification",{"name":28,"count":22},"Coronary Artery Disease",{"name":30,"count":22},"Vitreoretinal Surgeries",{"name":32,"count":22},"Postoperative Nausea and Vomiting",[34,39,44,49,54,59,64],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06878014","Comparing the Safety and Effectiveness of Different Doses of Morphine Administered in Spinal Anethesia for Pain Relief After Hip Replacement Surgery","2026-06-28","Postoperative pain management with acetaminophen",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT07013552","Oritavancin for CIED Infections With MDR Gram-positive Cocci","2026-07","Administration of a single or repeated dose of a long half-life antibiotic - oritavancin",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT07278999","Photobiomodulation, Photodynamic Therapy, and Clobetasol in the Treatment of Oral Lichen Planus.","2026-10","Clobetasol propionate 0.05 percent topical application",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT06027073","Biologics and Sublingual Immunotherapy","2026-10-01","omalizumab",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT07282756","Evaluation Of The Efficacy Of Subgingival Application Of Lovastatin Gel As An Adjunct To Non-Surgical Treatment Of Periodontitis In Generally Healthy Smokers And Non-Smokers Patients in Central Europe.","2026-12","Subgingival application of 1.2% lovastatin",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT07434427","Comparison of the Efficacy and Safety of Intravenous Buprenorphine Administered Via PCA System Versus Oxycodone in the Management of Postoperative Pain After Video-Assisted Thoracoscopic Surgery","2027-05","Group B",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT06212674","Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation","2027-10-31","NOAC",[70,71,72,73,74,75],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[77,107,125,143,161,188,206,229,251,275,300,318,346,364,401,428,446,471,497,523,541,570,588,616,642,668,693,718,745,770,797,815,833,873,925,955,977,1002,1030,1054,1081,1099,1117,1135,1153,1171,1197,1215,1242,1260,1278,1296,1324,1342,1360,1378,1396,1414,1438,1456,1474],{"intervention":38,"totalTrials":78,"cells":79},1,{"EARLY_PHASE1":80,"PHASE1":83,"PHASE2":85,"PHASE3":87,"PHASE4":89,"NA":105},{"trials":81,"activeCount":82},[],0,{"trials":84,"activeCount":82},[],{"trials":86,"activeCount":82},[],{"trials":88,"activeCount":82},[],{"trials":90,"activeCount":78,"soonestReadout":37},[91],{"nctId":35,"briefTitle":36,"status":92,"phases":93,"primaryCompletion":37,"completion":37,"start":94,"enrollment":95,"conditions":96,"interventions":101},"RECRUITING",[74],"2025-03-04",120,[97,98,99,100],"Analgesics, Opioid","Anesthesia, Spinal","Total Hip Replacement","Adverse Anesthesia Outcome",[38,102,103,104],"Postoperative pain management with dexketoprofen","Postoperative pain management with metamizole","Preemptive Analgesics",{"trials":106,"activeCount":82},[],{"intervention":102,"totalTrials":78,"cells":108},{"EARLY_PHASE1":109,"PHASE1":111,"PHASE2":113,"PHASE3":115,"PHASE4":117,"NA":123},{"trials":110,"activeCount":82},[],{"trials":112,"activeCount":82},[],{"trials":114,"activeCount":82},[],{"trials":116,"activeCount":82},[],{"trials":118,"activeCount":78,"soonestReadout":37},[119],{"nctId":35,"briefTitle":36,"status":92,"phases":120,"primaryCompletion":37,"completion":37,"start":94,"enrollment":95,"conditions":121,"interventions":122},[74],[97,98,99,100],[38,102,103,104],{"trials":124,"activeCount":82},[],{"intervention":103,"totalTrials":78,"cells":126},{"EARLY_PHASE1":127,"PHASE1":129,"PHASE2":131,"PHASE3":133,"PHASE4":135,"NA":141},{"trials":128,"activeCount":82},[],{"trials":130,"activeCount":82},[],{"trials":132,"activeCount":82},[],{"trials":134,"activeCount":82},[],{"trials":136,"activeCount":78,"soonestReadout":37},[137],{"nctId":35,"briefTitle":36,"status":92,"phases":138,"primaryCompletion":37,"completion":37,"start":94,"enrollment":95,"conditions":139,"interventions":140},[74],[97,98,99,100],[38,102,103,104],{"trials":142,"activeCount":82},[],{"intervention":104,"totalTrials":78,"cells":144},{"EARLY_PHASE1":145,"PHASE1":147,"PHASE2":149,"PHASE3":151,"PHASE4":153,"NA":159},{"trials":146,"activeCount":82},[],{"trials":148,"activeCount":82},[],{"trials":150,"activeCount":82},[],{"trials":152,"activeCount":82},[],{"trials":154,"activeCount":78,"soonestReadout":37},[155],{"nctId":35,"briefTitle":36,"status":92,"phases":156,"primaryCompletion":37,"completion":37,"start":94,"enrollment":95,"conditions":157,"interventions":158},[74],[97,98,99,100],[38,102,103,104],{"trials":160,"activeCount":82},[],{"intervention":63,"totalTrials":78,"cells":162},{"EARLY_PHASE1":163,"PHASE1":165,"PHASE2":167,"PHASE3":169,"PHASE4":171,"NA":186},{"trials":164,"activeCount":82},[],{"trials":166,"activeCount":82},[],{"trials":168,"activeCount":82},[],{"trials":170,"activeCount":82},[],{"trials":172,"activeCount":78,"soonestReadout":62},[173],{"nctId":60,"briefTitle":61,"status":174,"phases":175,"primaryCompletion":62,"completion":176,"start":177,"enrollment":178,"conditions":179,"interventions":184},"NOT_YET_RECRUITING",[74],"2027-11","2026-02",200,[180,181,182,183],"Acute Postoperative Pain","Chronic Postoperative Pain","Toracosurgery","Video-assisted Thoracis Surgery (VATS)",[63,185],"Group O",{"trials":187,"activeCount":82},[],{"intervention":185,"totalTrials":78,"cells":189},{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":194,"PHASE3":196,"PHASE4":198,"NA":204},{"trials":191,"activeCount":82},[],{"trials":193,"activeCount":82},[],{"trials":195,"activeCount":82},[],{"trials":197,"activeCount":82},[],{"trials":199,"activeCount":78,"soonestReadout":62},[200],{"nctId":60,"briefTitle":61,"status":174,"phases":201,"primaryCompletion":62,"completion":176,"start":177,"enrollment":178,"conditions":202,"interventions":203},[74],[180,181,182,183],[63,185],{"trials":205,"activeCount":82},[],{"intervention":68,"totalTrials":78,"cells":207},{"EARLY_PHASE1":208,"PHASE1":210,"PHASE2":212,"PHASE3":214,"PHASE4":216,"NA":227},{"trials":209,"activeCount":82},[],{"trials":211,"activeCount":82},[],{"trials":213,"activeCount":82},[],{"trials":215,"activeCount":82},[],{"trials":217,"activeCount":78,"soonestReadout":67},[218],{"nctId":65,"briefTitle":66,"status":92,"phases":219,"primaryCompletion":67,"completion":220,"start":221,"enrollment":222,"conditions":223,"interventions":226},[74],"2030-10-31","2025-10-31",240,[224,225],"Ischemic Stroke","Atrial Fibrillation",[68],{"trials":228,"activeCount":82},[],{"intervention":53,"totalTrials":78,"cells":230},{"EARLY_PHASE1":231,"PHASE1":233,"PHASE2":235,"PHASE3":237,"PHASE4":239,"NA":249},{"trials":232,"activeCount":82},[],{"trials":234,"activeCount":82},[],{"trials":236,"activeCount":82},[],{"trials":238,"activeCount":82},[],{"trials":240,"activeCount":78,"soonestReadout":52},[241],{"nctId":50,"briefTitle":51,"status":174,"phases":242,"primaryCompletion":52,"completion":243,"start":244,"enrollment":245,"conditions":246,"interventions":248},[74],"2028-03-01","2024-05-01",150,[247],"Asthma, Allergic",[53],{"trials":250,"activeCount":82},[],{"intervention":48,"totalTrials":78,"cells":252},{"EARLY_PHASE1":253,"PHASE1":255,"PHASE2":257,"PHASE3":259,"PHASE4":261,"NA":263},{"trials":254,"activeCount":82},[],{"trials":256,"activeCount":82},[],{"trials":258,"activeCount":82},[],{"trials":260,"activeCount":82},[],{"trials":262,"activeCount":82},[],{"trials":264,"activeCount":78,"soonestReadout":47},[265],{"nctId":45,"briefTitle":46,"status":92,"phases":266,"primaryCompletion":47,"completion":267,"start":268,"enrollment":269,"conditions":270,"interventions":274},[75],"2026-11","2025-12-01",60,[271,272,273],"Oral Lichen Planus","Erosive Lichen Planus","Mucosal Lesions",[48],{"intervention":58,"totalTrials":78,"cells":276},{"EARLY_PHASE1":277,"PHASE1":279,"PHASE2":281,"PHASE3":283,"PHASE4":285,"NA":287},{"trials":278,"activeCount":82},[],{"trials":280,"activeCount":82},[],{"trials":282,"activeCount":82},[],{"trials":284,"activeCount":82},[],{"trials":286,"activeCount":82},[],{"trials":288,"activeCount":78,"soonestReadout":57},[289],{"nctId":55,"briefTitle":56,"status":92,"phases":290,"primaryCompletion":57,"completion":57,"start":291,"enrollment":292,"conditions":293,"interventions":298},[75],"2025-07-11",44,[294,295,296,297],"Periodontal Diseases","Periodontitis","Periodontal Disease","Smokers",[58,299],"Subgingival application of placebo gel",{"intervention":299,"totalTrials":78,"cells":301},{"EARLY_PHASE1":302,"PHASE1":304,"PHASE2":306,"PHASE3":308,"PHASE4":310,"NA":312},{"trials":303,"activeCount":82},[],{"trials":305,"activeCount":82},[],{"trials":307,"activeCount":82},[],{"trials":309,"activeCount":82},[],{"trials":311,"activeCount":82},[],{"trials":313,"activeCount":78,"soonestReadout":57},[314],{"nctId":55,"briefTitle":56,"status":92,"phases":315,"primaryCompletion":57,"completion":57,"start":291,"enrollment":292,"conditions":316,"interventions":317},[75],[294,295,296,297],[58,299],{"intervention":43,"totalTrials":78,"cells":319},{"EARLY_PHASE1":320,"PHASE1":322,"PHASE2":324,"PHASE3":326,"PHASE4":328,"NA":330},{"trials":321,"activeCount":82},[],{"trials":323,"activeCount":82},[],{"trials":325,"activeCount":82},[],{"trials":327,"activeCount":82},[],{"trials":329,"activeCount":82},[],{"trials":331,"activeCount":78,"soonestReadout":42},[332],{"nctId":40,"briefTitle":41,"status":174,"phases":333,"primaryCompletion":42,"completion":47,"start":334,"enrollment":335,"conditions":336,"interventions":344},[75],"2025-06",100,[337,338,339,340,341,342,343],"Cardiac Implantable Electronic Device Infections","Infective Endocarditis","Multidrug-resistant Bacteria Screening","Gram Positive Bacterial Infection","Antibiotic Resistant Strain","Antibiotic Therapy","Healthcare Associated Infections",[43,345],"Administration of a repeated dose of a short half-life antibiotic - vancomycin",{"intervention":345,"totalTrials":78,"cells":347},{"EARLY_PHASE1":348,"PHASE1":350,"PHASE2":352,"PHASE3":354,"PHASE4":356,"NA":358},{"trials":349,"activeCount":82},[],{"trials":351,"activeCount":82},[],{"trials":353,"activeCount":82},[],{"trials":355,"activeCount":82},[],{"trials":357,"activeCount":82},[],{"trials":359,"activeCount":78,"soonestReadout":42},[360],{"nctId":40,"briefTitle":41,"status":174,"phases":361,"primaryCompletion":42,"completion":47,"start":334,"enrollment":335,"conditions":362,"interventions":363},[75],[337,338,339,340,341,342,343],[43,345],{"intervention":365,"totalTrials":366,"cells":367},"Verapamil",2,{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":376,"NA":399},{"trials":369,"activeCount":82},[],{"trials":371,"activeCount":82},[],{"trials":373,"activeCount":82},[],{"trials":375,"activeCount":82},[],{"trials":377,"activeCount":82},[378,390],{"nctId":379,"briefTitle":380,"status":381,"phases":382,"completion":383,"start":384,"enrollment":95,"conditions":385,"interventions":389},"NCT00348530","Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy","UNKNOWN",[74],"2007-12","2006-01",[386,387,388],"Systolic Heart Failure","Myocardial Disease","Cardiomyopathy",[365],{"nctId":391,"briefTitle":392,"status":381,"phases":393,"completion":394,"start":384,"enrollment":335,"conditions":395,"interventions":397},"NCT00374465","Therapy With Verapamil or Carvedilol in Chronic Heart Failure",[74],"2008-05",[396],"Dilated Cardiomyopathy",[365,398],"Carvedilol",{"trials":400,"activeCount":82},[],{"intervention":402,"totalTrials":78,"cells":403},"Purethal",{"EARLY_PHASE1":404,"PHASE1":406,"PHASE2":408,"PHASE3":410,"PHASE4":412,"NA":426},{"trials":405,"activeCount":82},[],{"trials":407,"activeCount":82},[],{"trials":409,"activeCount":82},[],{"trials":411,"activeCount":82},[],{"trials":413,"activeCount":82},[414],{"nctId":415,"briefTitle":416,"status":417,"phases":418,"primaryCompletion":419,"completion":420,"start":421,"enrollment":95,"conditions":422,"interventions":424},"NCT02440243","Grass Pollen Subcutaneous Immunotherapy in Elderly Patients","COMPLETED",[74],"2014-09","2014-12","2011-01",[423],"Allergy",[402,425],"Purethal -placebo",{"trials":427,"activeCount":82},[],{"intervention":425,"totalTrials":78,"cells":429},{"EARLY_PHASE1":430,"PHASE1":432,"PHASE2":434,"PHASE3":436,"PHASE4":438,"NA":444},{"trials":431,"activeCount":82},[],{"trials":433,"activeCount":82},[],{"trials":435,"activeCount":82},[],{"trials":437,"activeCount":82},[],{"trials":439,"activeCount":82},[440],{"nctId":415,"briefTitle":416,"status":417,"phases":441,"primaryCompletion":419,"completion":420,"start":421,"enrollment":95,"conditions":442,"interventions":443},[74],[423],[402,425],{"trials":445,"activeCount":82},[],{"intervention":447,"totalTrials":78,"cells":448},"Eptifibatide",{"EARLY_PHASE1":449,"PHASE1":451,"PHASE2":453,"PHASE3":455,"PHASE4":457,"NA":469},{"trials":450,"activeCount":82},[],{"trials":452,"activeCount":82},[],{"trials":454,"activeCount":82},[],{"trials":456,"activeCount":82},[],{"trials":458,"activeCount":82},[459],{"nctId":460,"briefTitle":461,"status":417,"phases":462,"primaryCompletion":463,"completion":463,"start":464,"enrollment":465,"conditions":466,"interventions":468},"NCT01863134","Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up",[74],"2010-12","2005-01",140,[467],"Non ST Elevation Myocardial Infarction",[447],{"trials":470,"activeCount":82},[],{"intervention":472,"totalTrials":78,"cells":473},"Pembrolizumab",{"EARLY_PHASE1":474,"PHASE1":476,"PHASE2":478,"PHASE3":480,"PHASE4":482,"NA":495},{"trials":475,"activeCount":82},[],{"trials":477,"activeCount":82},[],{"trials":479,"activeCount":82},[],{"trials":481,"activeCount":82},[],{"trials":483,"activeCount":82},[484],{"nctId":485,"briefTitle":486,"status":381,"phases":487,"primaryCompletion":488,"completion":489,"start":490,"enrollment":491,"conditions":492,"interventions":494},"NCT05235737","The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab",[74],"2025-06-01","2026-05-30","2022-03-01",36,[493],"Newly Diagnosed Glioblastoma",[472,472],{"trials":496,"activeCount":82},[],{"intervention":498,"totalTrials":78,"cells":499},"immunotherapy Staloral",{"EARLY_PHASE1":500,"PHASE1":502,"PHASE2":504,"PHASE3":506,"PHASE4":508,"NA":521},{"trials":501,"activeCount":82},[],{"trials":503,"activeCount":82},[],{"trials":505,"activeCount":82},[],{"trials":507,"activeCount":82},[],{"trials":509,"activeCount":82},[510],{"nctId":511,"briefTitle":512,"status":417,"phases":513,"primaryCompletion":514,"completion":515,"start":516,"enrollment":517,"conditions":518,"interventions":520},"NCT01605760","House Dust Mite SLIT in Elderly Patients",[74],"2012-01","2012-03","2008-01",111,[519],"Allergic Rhinitis",[498],{"trials":522,"activeCount":82},[],{"intervention":398,"totalTrials":78,"cells":524},{"EARLY_PHASE1":525,"PHASE1":527,"PHASE2":529,"PHASE3":531,"PHASE4":533,"NA":539},{"trials":526,"activeCount":82},[],{"trials":528,"activeCount":82},[],{"trials":530,"activeCount":82},[],{"trials":532,"activeCount":82},[],{"trials":534,"activeCount":82},[535],{"nctId":391,"briefTitle":392,"status":381,"phases":536,"completion":394,"start":384,"enrollment":335,"conditions":537,"interventions":538},[74],[396],[365,398],{"trials":540,"activeCount":82},[],{"intervention":542,"totalTrials":78,"cells":543},"5% polymer gel with CBD application",{"EARLY_PHASE1":544,"PHASE1":546,"PHASE2":548,"PHASE3":550,"PHASE4":566,"NA":568},{"trials":545,"activeCount":82},[],{"trials":547,"activeCount":82},[],{"trials":549,"activeCount":82},[],{"trials":551,"activeCount":82},[552],{"nctId":553,"briefTitle":554,"status":381,"phases":555,"primaryCompletion":556,"completion":557,"start":558,"enrollment":559,"conditions":560,"interventions":564},"NCT05562635","CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)",[72,73],"2023-07-30","2023-08-30","2023-07-18",30,[15,24,561,562,563],"Orofacial Pain","CBD","Bruxism",[542,565],"10% polymer gel with CBD application",{"trials":567,"activeCount":82},[],{"trials":569,"activeCount":82},[],{"intervention":565,"totalTrials":78,"cells":571},{"EARLY_PHASE1":572,"PHASE1":574,"PHASE2":576,"PHASE3":578,"PHASE4":584,"NA":586},{"trials":573,"activeCount":82},[],{"trials":575,"activeCount":82},[],{"trials":577,"activeCount":82},[],{"trials":579,"activeCount":82},[580],{"nctId":553,"briefTitle":554,"status":381,"phases":581,"primaryCompletion":556,"completion":557,"start":558,"enrollment":559,"conditions":582,"interventions":583},[72,73],[15,24,561,562,563],[542,565],{"trials":585,"activeCount":82},[],{"trials":587,"activeCount":82},[],{"intervention":589,"totalTrials":78,"cells":590},"CBD occlusal appliance",{"EARLY_PHASE1":591,"PHASE1":593,"PHASE2":595,"PHASE3":597,"PHASE4":612,"NA":614},{"trials":592,"activeCount":82},[],{"trials":594,"activeCount":82},[],{"trials":596,"activeCount":82},[],{"trials":598,"activeCount":82},[599],{"nctId":600,"briefTitle":601,"status":381,"phases":602,"primaryCompletion":603,"completion":604,"start":605,"enrollment":606,"conditions":607,"interventions":611},"NCT04775030","Methodology for Developing an Occlusal Appliance With CBD Active Carrier",[72,73],"2022-01-01","2023-01-01","2021-01-01",40,[15,24,608,609,610,562],"Cannabis","Electromyography","Occlusal Appliance",[589],{"trials":613,"activeCount":82},[],{"trials":615,"activeCount":82},[],{"intervention":617,"totalTrials":78,"cells":618},"Purethal Birch immunotherapy",{"EARLY_PHASE1":619,"PHASE1":621,"PHASE2":623,"PHASE3":625,"PHASE4":638,"NA":640},{"trials":620,"activeCount":82},[],{"trials":622,"activeCount":82},[],{"trials":624,"activeCount":82},[],{"trials":626,"activeCount":82},[627],{"nctId":628,"briefTitle":629,"status":417,"phases":630,"primaryCompletion":631,"completion":632,"start":633,"enrollment":634,"conditions":635,"interventions":637},"NCT03157505","Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis",[73],"2016-12-30","2017-03-02","2014-01-05",78,[519,636],"Allergic Reaction",[617],{"trials":639,"activeCount":82},[],{"trials":641,"activeCount":82},[],{"intervention":643,"totalTrials":78,"cells":644},"Purethal Mites",{"EARLY_PHASE1":645,"PHASE1":647,"PHASE2":649,"PHASE3":651,"PHASE4":664,"NA":666},{"trials":646,"activeCount":82},[],{"trials":648,"activeCount":82},[],{"trials":650,"activeCount":82},[],{"trials":652,"activeCount":82},[653],{"nctId":654,"briefTitle":655,"status":417,"phases":656,"primaryCompletion":657,"completion":658,"start":659,"enrollment":660,"conditions":661,"interventions":663},"NCT03209245","House Dust Mite Injection Immunotherapy in Elderly Patients.",[73],"2016-06-20","2017-04-15","2014-04-10",58,[662],"Allergen Immunotherapy in Elderly Patients",[643],{"trials":665,"activeCount":82},[],{"trials":667,"activeCount":82},[],{"intervention":669,"totalTrials":78,"cells":670},"Cannabis Cream",{"EARLY_PHASE1":671,"PHASE1":673,"PHASE2":675,"PHASE3":677,"PHASE4":689,"NA":691},{"trials":672,"activeCount":82},[],{"trials":674,"activeCount":82},[],{"trials":676,"activeCount":82},[],{"trials":678,"activeCount":82},[679],{"nctId":680,"briefTitle":681,"status":417,"phases":682,"primaryCompletion":683,"completion":684,"start":685,"enrollment":686,"conditions":687,"interventions":688},"NCT03994640","Myorelaxant Effect of Cannabis Cream Topical Skin Application in Patients With TMD",[72,73],"2018-10-01","2019-01-01","2018-01-01",20,[15,24,608,609],[669],{"trials":690,"activeCount":82},[],{"trials":692,"activeCount":82},[],{"intervention":694,"totalTrials":78,"cells":695},"Platelet-Rich Plasma intramuscular injections",{"EARLY_PHASE1":696,"PHASE1":698,"PHASE2":700,"PHASE3":702,"PHASE4":714,"NA":716},{"trials":697,"activeCount":82},[],{"trials":699,"activeCount":82},[],{"trials":701,"activeCount":82},[],{"trials":703,"activeCount":82},[704],{"nctId":705,"briefTitle":706,"status":417,"phases":707,"primaryCompletion":708,"completion":684,"start":709,"enrollment":660,"conditions":710,"interventions":713},"NCT03371888","The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders",[72,73],"2018-12-15","2017-12-07",[711,15,712,563],"PRP","Myalgia",[694],{"trials":715,"activeCount":82},[],{"trials":717,"activeCount":82},[],{"intervention":719,"totalTrials":78,"cells":720},"Patients will receive initial chemotherapy, followed by evaluation of the response to the treatment, followed by SBRT, followed by chemotherapy.",{"EARLY_PHASE1":721,"PHASE1":723,"PHASE2":725,"PHASE3":739,"PHASE4":741,"NA":743},{"trials":722,"activeCount":82},[],{"trials":724,"activeCount":82},[],{"trials":726,"activeCount":82},[727],{"nctId":728,"briefTitle":729,"status":417,"phases":730,"primaryCompletion":731,"completion":731,"start":732,"enrollment":606,"conditions":733,"interventions":738},"NCT03891472","Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer",[72],"2019-07-31","2017-01-01",[734,735,736,737],"Cancer of Pancreas","Unresectable Pancreatic Cancer","Chemotherapy Effect","SBRT",[719],{"trials":740,"activeCount":82},[],{"trials":742,"activeCount":82},[],{"trials":744,"activeCount":82},[],{"intervention":746,"totalTrials":78,"cells":747},"intramyocardial",{"EARLY_PHASE1":748,"PHASE1":750,"PHASE2":752,"PHASE3":764,"PHASE4":766,"NA":768},{"trials":749,"activeCount":82},[],{"trials":751,"activeCount":82},[],{"trials":753,"activeCount":82},[754],{"nctId":755,"briefTitle":756,"status":417,"phases":757,"primaryCompletion":758,"completion":758,"start":759,"enrollment":760,"conditions":761,"interventions":763},"NCT01660581","Intracardiac CD133+ Cells in Patients With No-option Resistant Angina",[72],"2016-09","2012-06",31,[762],"Stable Angina",[746],{"trials":765,"activeCount":82},[],{"trials":767,"activeCount":82},[],{"trials":769,"activeCount":82},[],{"intervention":771,"totalTrials":78,"cells":772},"MD Muscle GUNA collagen",{"EARLY_PHASE1":773,"PHASE1":787,"PHASE2":789,"PHASE3":791,"PHASE4":793,"NA":795},{"trials":774,"activeCount":82},[775],{"nctId":776,"briefTitle":777,"status":417,"phases":778,"primaryCompletion":779,"completion":780,"start":781,"enrollment":782,"conditions":783,"interventions":784},"NCT03323567","A Comparison of Collagen, Lidocaine and Saline, in Trigger Points in Masseter Muscle.",[70],"2017-10-04","2017-10-12","2016-01-10",43,[15],[771,785,786],"Lidocaine 2% Injectable Solution","Saline Solution, Hypertonic",{"trials":788,"activeCount":82},[],{"trials":790,"activeCount":82},[],{"trials":792,"activeCount":82},[],{"trials":794,"activeCount":82},[],{"trials":796,"activeCount":82},[],{"intervention":785,"totalTrials":78,"cells":798},{"EARLY_PHASE1":799,"PHASE1":805,"PHASE2":807,"PHASE3":809,"PHASE4":811,"NA":813},{"trials":800,"activeCount":82},[801],{"nctId":776,"briefTitle":777,"status":417,"phases":802,"primaryCompletion":779,"completion":780,"start":781,"enrollment":782,"conditions":803,"interventions":804},[70],[15],[771,785,786],{"trials":806,"activeCount":82},[],{"trials":808,"activeCount":82},[],{"trials":810,"activeCount":82},[],{"trials":812,"activeCount":82},[],{"trials":814,"activeCount":82},[],{"intervention":786,"totalTrials":78,"cells":816},{"EARLY_PHASE1":817,"PHASE1":823,"PHASE2":825,"PHASE3":827,"PHASE4":829,"NA":831},{"trials":818,"activeCount":82},[819],{"nctId":776,"briefTitle":777,"status":417,"phases":820,"primaryCompletion":779,"completion":780,"start":781,"enrollment":782,"conditions":821,"interventions":822},[70],[15],[771,785,786],{"trials":824,"activeCount":82},[],{"trials":826,"activeCount":82},[],{"trials":828,"activeCount":82},[],{"trials":830,"activeCount":82},[],{"trials":832,"activeCount":82},[],{"intervention":834,"totalTrials":22,"cells":835},"Remifentanil",{"EARLY_PHASE1":836,"PHASE1":838,"PHASE2":840,"PHASE3":842,"PHASE4":844,"NA":846},{"trials":837,"activeCount":82},[],{"trials":839,"activeCount":82},[],{"trials":841,"activeCount":82},[],{"trials":843,"activeCount":82},[],{"trials":845,"activeCount":82},[],{"trials":847,"activeCount":82},[848,856,865],{"nctId":849,"briefTitle":850,"status":381,"phases":851,"primaryCompletion":852,"completion":852,"start":853,"enrollment":95,"conditions":854,"interventions":855},"NCT03417180","SPI-guided Analgesia During FESS for Intraoperative Blood Loss",[75],"2023-07-15","2018-09-01",[21],[834],{"nctId":857,"briefTitle":858,"status":417,"phases":859,"primaryCompletion":860,"completion":860,"start":861,"enrollment":862,"conditions":863,"interventions":864},"NCT03389763","SPI-guided vs PRD-guided Analgesia During FESS for Intraoperative Blood Loss",[75],"2018-01-15","2016-06-01",105,[21],[834],{"nctId":866,"briefTitle":867,"status":381,"phases":868,"primaryCompletion":869,"completion":869,"start":870,"enrollment":95,"conditions":871,"interventions":872},"NCT03417206","PRD-guided Analgesia During FESS for Intraoperative Blood Loss",[75],"2023-01-15","2021-09-01",[21],[834],{"intervention":874,"totalTrials":22,"cells":875},"Metamizol",{"EARLY_PHASE1":876,"PHASE1":878,"PHASE2":880,"PHASE3":882,"PHASE4":884,"NA":886},{"trials":877,"activeCount":82},[],{"trials":879,"activeCount":82},[],{"trials":881,"activeCount":82},[],{"trials":883,"activeCount":82},[],{"trials":885,"activeCount":82},[],{"trials":887,"activeCount":82},[888,901,913],{"nctId":889,"briefTitle":890,"status":417,"phases":891,"primaryCompletion":892,"completion":892,"start":893,"enrollment":894,"conditions":895,"interventions":897},"NCT02971540","SPI-directed Analgesia for Lumbar Discectomy",[75],"2017-07-30","2016-02",132,[896],"Lumbar Disc Disease",[874,898,899,900],"Tramadol","Bupivacaine","Ropivacaine",{"nctId":902,"briefTitle":903,"status":417,"phases":904,"primaryCompletion":905,"completion":906,"start":860,"enrollment":907,"conditions":908,"interventions":910},"NCT03389243","Paracetamol and Metamizole With SPI-guided Anaesthesia for VRS",[75],"2021-09-16","2022-12-16",165,[30,32,909],"Postoperative Pain",[874,911,912],"paracetamol","paracetamol and metamizole",{"nctId":914,"briefTitle":915,"status":417,"phases":916,"primaryCompletion":917,"completion":918,"start":893,"enrollment":919,"conditions":920,"interventions":921},"NCT02973581","SPI-directed Analgesia for Vitreoretinal Surgeries",[75],"2017-02","2017-05",176,[30,32,909],[874,922,923,924],"Acetaminophen","0,5 % bupivacaine with of 2% lidocaine","Proxymetacaine",{"intervention":911,"totalTrials":366,"cells":926},{"EARLY_PHASE1":927,"PHASE1":929,"PHASE2":931,"PHASE3":933,"PHASE4":935,"NA":937},{"trials":928,"activeCount":82},[],{"trials":930,"activeCount":82},[],{"trials":932,"activeCount":82},[],{"trials":934,"activeCount":82},[],{"trials":936,"activeCount":82},[],{"trials":938,"activeCount":82},[939,951],{"nctId":940,"briefTitle":941,"status":417,"phases":942,"primaryCompletion":943,"completion":943,"start":944,"enrollment":945,"conditions":946,"interventions":948},"NCT03413371","Different Peribulbar Blocks With SPI-guided Anaesthesia for VRS (P&MSPIVRS)",[75],"2022-12-20","2018-04-26",184,[30,32,909,947],"Oculocardiac Reflex",[911,923,949,950],"1 % Ropivacaine","0,5 % bupivacaine",{"nctId":902,"briefTitle":903,"status":417,"phases":952,"primaryCompletion":905,"completion":906,"start":860,"enrollment":907,"conditions":953,"interventions":954},[75],[30,32,909],[874,911,912],{"intervention":923,"totalTrials":366,"cells":956},{"EARLY_PHASE1":957,"PHASE1":959,"PHASE2":961,"PHASE3":963,"PHASE4":965,"NA":967},{"trials":958,"activeCount":82},[],{"trials":960,"activeCount":82},[],{"trials":962,"activeCount":82},[],{"trials":964,"activeCount":82},[],{"trials":966,"activeCount":82},[],{"trials":968,"activeCount":82},[969,973],{"nctId":940,"briefTitle":941,"status":417,"phases":970,"primaryCompletion":943,"completion":943,"start":944,"enrollment":945,"conditions":971,"interventions":972},[75],[30,32,909,947],[911,923,949,950],{"nctId":914,"briefTitle":915,"status":417,"phases":974,"primaryCompletion":917,"completion":918,"start":893,"enrollment":919,"conditions":975,"interventions":976},[75],[30,32,909],[874,922,923,924],{"intervention":978,"totalTrials":78,"cells":979},"To compare monotherapies and combined therapy with each other",{"EARLY_PHASE1":980,"PHASE1":982,"PHASE2":984,"PHASE3":986,"PHASE4":988,"NA":990},{"trials":981,"activeCount":82},[],{"trials":983,"activeCount":82},[],{"trials":985,"activeCount":82},[],{"trials":987,"activeCount":82},[],{"trials":989,"activeCount":82},[],{"trials":991,"activeCount":82},[992],{"nctId":993,"briefTitle":994,"status":417,"phases":995,"primaryCompletion":996,"completion":997,"start":394,"enrollment":634,"conditions":998,"interventions":1001},"NCT01099176","Effects of Hypolipemic Treatment on Adipokines",[75],"2009-05","2009-09",[999,1000],"Hyperlipidemia","Impaired Fasting Glycemia",[978],{"intervention":1003,"totalTrials":78,"cells":1004},"Metformin 1000mg, simvastatin 10mg and fenofibrate 100mg",{"EARLY_PHASE1":1005,"PHASE1":1007,"PHASE2":1009,"PHASE3":1011,"PHASE4":1013,"NA":1015},{"trials":1006,"activeCount":82},[],{"trials":1008,"activeCount":82},[],{"trials":1010,"activeCount":82},[],{"trials":1012,"activeCount":82},[],{"trials":1014,"activeCount":82},[],{"trials":1016,"activeCount":82},[1017],{"nctId":1018,"briefTitle":1019,"status":381,"phases":1020,"primaryCompletion":1021,"completion":1022,"start":1023,"enrollment":178,"conditions":1024,"interventions":1029},"NCT01101204","The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines",[75],"2012-10","2012-12","2012-07",[1025,1026,1027,1028],"Diabetes","Dyslipidemia","Inflammation","Cytokines",[1003],{"intervention":1031,"totalTrials":78,"cells":1032},"rabbit anti-thymocyte globulin",{"EARLY_PHASE1":1033,"PHASE1":1035,"PHASE2":1037,"PHASE3":1039,"PHASE4":1041,"NA":1043},{"trials":1034,"activeCount":82},[],{"trials":1036,"activeCount":82},[],{"trials":1038,"activeCount":82},[],{"trials":1040,"activeCount":82},[],{"trials":1042,"activeCount":82},[],{"trials":1044,"activeCount":82},[1045],{"nctId":1046,"briefTitle":1047,"status":381,"phases":1048,"primaryCompletion":1049,"completion":1049,"start":1050,"enrollment":686,"conditions":1051,"interventions":1053},"NCT05199103","Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy",[75],"2023-12-31","2020-01-01",[1052],"Graves Orbitopathy",[1031],{"intervention":1055,"totalTrials":78,"cells":1056},"tablets Acarizax",{"EARLY_PHASE1":1057,"PHASE1":1059,"PHASE2":1061,"PHASE3":1063,"PHASE4":1065,"NA":1067},{"trials":1058,"activeCount":82},[],{"trials":1060,"activeCount":82},[],{"trials":1062,"activeCount":82},[],{"trials":1064,"activeCount":82},[],{"trials":1066,"activeCount":82},[],{"trials":1068,"activeCount":82},[1069],{"nctId":1070,"briefTitle":1071,"status":417,"phases":1072,"primaryCompletion":1073,"completion":1074,"start":1075,"enrollment":894,"conditions":1076,"interventions":1078},"NCT06509243","Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic Dermatitis",[75],"2024-03-12","2024-04-10","2023-02-10",[1077],"Atopic Dermatitis",[1055,1079,1080],"dupilumab","cyclosporine",{"intervention":1079,"totalTrials":78,"cells":1082},{"EARLY_PHASE1":1083,"PHASE1":1085,"PHASE2":1087,"PHASE3":1089,"PHASE4":1091,"NA":1093},{"trials":1084,"activeCount":82},[],{"trials":1086,"activeCount":82},[],{"trials":1088,"activeCount":82},[],{"trials":1090,"activeCount":82},[],{"trials":1092,"activeCount":82},[],{"trials":1094,"activeCount":82},[1095],{"nctId":1070,"briefTitle":1071,"status":417,"phases":1096,"primaryCompletion":1073,"completion":1074,"start":1075,"enrollment":894,"conditions":1097,"interventions":1098},[75],[1077],[1055,1079,1080],{"intervention":1080,"totalTrials":78,"cells":1100},{"EARLY_PHASE1":1101,"PHASE1":1103,"PHASE2":1105,"PHASE3":1107,"PHASE4":1109,"NA":1111},{"trials":1102,"activeCount":82},[],{"trials":1104,"activeCount":82},[],{"trials":1106,"activeCount":82},[],{"trials":1108,"activeCount":82},[],{"trials":1110,"activeCount":82},[],{"trials":1112,"activeCount":82},[1113],{"nctId":1070,"briefTitle":1071,"status":417,"phases":1114,"primaryCompletion":1073,"completion":1074,"start":1075,"enrollment":894,"conditions":1115,"interventions":1116},[75],[1077],[1055,1079,1080],{"intervention":898,"totalTrials":78,"cells":1118},{"EARLY_PHASE1":1119,"PHASE1":1121,"PHASE2":1123,"PHASE3":1125,"PHASE4":1127,"NA":1129},{"trials":1120,"activeCount":82},[],{"trials":1122,"activeCount":82},[],{"trials":1124,"activeCount":82},[],{"trials":1126,"activeCount":82},[],{"trials":1128,"activeCount":82},[],{"trials":1130,"activeCount":82},[1131],{"nctId":889,"briefTitle":890,"status":417,"phases":1132,"primaryCompletion":892,"completion":892,"start":893,"enrollment":894,"conditions":1133,"interventions":1134},[75],[896],[874,898,899,900],{"intervention":899,"totalTrials":78,"cells":1136},{"EARLY_PHASE1":1137,"PHASE1":1139,"PHASE2":1141,"PHASE3":1143,"PHASE4":1145,"NA":1147},{"trials":1138,"activeCount":82},[],{"trials":1140,"activeCount":82},[],{"trials":1142,"activeCount":82},[],{"trials":1144,"activeCount":82},[],{"trials":1146,"activeCount":82},[],{"trials":1148,"activeCount":82},[1149],{"nctId":889,"briefTitle":890,"status":417,"phases":1150,"primaryCompletion":892,"completion":892,"start":893,"enrollment":894,"conditions":1151,"interventions":1152},[75],[896],[874,898,899,900],{"intervention":900,"totalTrials":78,"cells":1154},{"EARLY_PHASE1":1155,"PHASE1":1157,"PHASE2":1159,"PHASE3":1161,"PHASE4":1163,"NA":1165},{"trials":1156,"activeCount":82},[],{"trials":1158,"activeCount":82},[],{"trials":1160,"activeCount":82},[],{"trials":1162,"activeCount":82},[],{"trials":1164,"activeCount":82},[],{"trials":1166,"activeCount":82},[1167],{"nctId":889,"briefTitle":890,"status":417,"phases":1168,"primaryCompletion":892,"completion":892,"start":893,"enrollment":894,"conditions":1169,"interventions":1170},[75],[896],[874,898,899,900],{"intervention":1172,"totalTrials":78,"cells":1173},"rescue fentanyl",{"EARLY_PHASE1":1174,"PHASE1":1176,"PHASE2":1178,"PHASE3":1180,"PHASE4":1182,"NA":1184},{"trials":1175,"activeCount":82},[],{"trials":1177,"activeCount":82},[],{"trials":1179,"activeCount":82},[],{"trials":1181,"activeCount":82},[],{"trials":1183,"activeCount":82},[],{"trials":1185,"activeCount":82},[1186],{"nctId":1187,"briefTitle":1188,"status":417,"phases":1189,"primaryCompletion":1190,"completion":1190,"start":1191,"enrollment":1192,"conditions":1193,"interventions":1195},"NCT03922815","Adequacy of Anaesthesia for Colonoscopic Procedures",[75],"2020-01-31","2019-09-01",158,[1194],"Colonic Diseases, Functional",[1172,1196],"rescue propofol",{"intervention":1196,"totalTrials":78,"cells":1198},{"EARLY_PHASE1":1199,"PHASE1":1201,"PHASE2":1203,"PHASE3":1205,"PHASE4":1207,"NA":1209},{"trials":1200,"activeCount":82},[],{"trials":1202,"activeCount":82},[],{"trials":1204,"activeCount":82},[],{"trials":1206,"activeCount":82},[],{"trials":1208,"activeCount":82},[],{"trials":1210,"activeCount":82},[1211],{"nctId":1187,"briefTitle":1188,"status":417,"phases":1212,"primaryCompletion":1190,"completion":1190,"start":1191,"enrollment":1192,"conditions":1213,"interventions":1214},[75],[1194],[1172,1196],{"intervention":1216,"totalTrials":78,"cells":1217},"Opioid Anesthesia",{"EARLY_PHASE1":1218,"PHASE1":1220,"PHASE2":1222,"PHASE3":1224,"PHASE4":1226,"NA":1228},{"trials":1219,"activeCount":82},[],{"trials":1221,"activeCount":82},[],{"trials":1223,"activeCount":82},[],{"trials":1225,"activeCount":82},[],{"trials":1227,"activeCount":82},[],{"trials":1229,"activeCount":82},[1230],{"nctId":1231,"briefTitle":1232,"status":417,"phases":1233,"primaryCompletion":1234,"completion":1234,"start":1235,"enrollment":1236,"conditions":1237,"interventions":1240},"NCT04355468","Opioid Free Anesthesia in Thoracic Surgery",[75],"2018-03","2015-12",66,[1238,97,1239],"Thoracic Surgery","Anesthesia, Conduction",[1216,1241],"Opioid Free Anaesthesia",{"intervention":1241,"totalTrials":78,"cells":1243},{"EARLY_PHASE1":1244,"PHASE1":1246,"PHASE2":1248,"PHASE3":1250,"PHASE4":1252,"NA":1254},{"trials":1245,"activeCount":82},[],{"trials":1247,"activeCount":82},[],{"trials":1249,"activeCount":82},[],{"trials":1251,"activeCount":82},[],{"trials":1253,"activeCount":82},[],{"trials":1255,"activeCount":82},[1256],{"nctId":1231,"briefTitle":1232,"status":417,"phases":1257,"primaryCompletion":1234,"completion":1234,"start":1235,"enrollment":1236,"conditions":1258,"interventions":1259},[75],[1238,97,1239],[1216,1241],{"intervention":949,"totalTrials":78,"cells":1261},{"EARLY_PHASE1":1262,"PHASE1":1264,"PHASE2":1266,"PHASE3":1268,"PHASE4":1270,"NA":1272},{"trials":1263,"activeCount":82},[],{"trials":1265,"activeCount":82},[],{"trials":1267,"activeCount":82},[],{"trials":1269,"activeCount":82},[],{"trials":1271,"activeCount":82},[],{"trials":1273,"activeCount":82},[1274],{"nctId":940,"briefTitle":941,"status":417,"phases":1275,"primaryCompletion":943,"completion":943,"start":944,"enrollment":945,"conditions":1276,"interventions":1277},[75],[30,32,909,947],[911,923,949,950],{"intervention":950,"totalTrials":78,"cells":1279},{"EARLY_PHASE1":1280,"PHASE1":1282,"PHASE2":1284,"PHASE3":1286,"PHASE4":1288,"NA":1290},{"trials":1281,"activeCount":82},[],{"trials":1283,"activeCount":82},[],{"trials":1285,"activeCount":82},[],{"trials":1287,"activeCount":82},[],{"trials":1289,"activeCount":82},[],{"trials":1291,"activeCount":82},[1292],{"nctId":940,"briefTitle":941,"status":417,"phases":1293,"primaryCompletion":943,"completion":943,"start":944,"enrollment":945,"conditions":1294,"interventions":1295},[75],[30,32,909,947],[911,923,949,950],{"intervention":1297,"totalTrials":78,"cells":1298},"infiltration rescue intraoperative analgesia",{"EARLY_PHASE1":1299,"PHASE1":1301,"PHASE2":1303,"PHASE3":1305,"PHASE4":1307,"NA":1309},{"trials":1300,"activeCount":82},[],{"trials":1302,"activeCount":82},[],{"trials":1304,"activeCount":82},[],{"trials":1306,"activeCount":82},[],{"trials":1308,"activeCount":82},[],{"trials":1310,"activeCount":82},[1311],{"nctId":1312,"briefTitle":1313,"status":381,"phases":1314,"primaryCompletion":1315,"completion":1315,"start":1316,"enrollment":862,"conditions":1317,"interventions":1319},"NCT04500249","SPI-guided Analgesia During CEA Under RA",[75],"2020-10-01","2015-10-01",[1318],"Carotid Artery Stenoses",[1297,1320,1321,1322,1323,1323],"rescue IA","rescue antyhypertensive medication","rescue antyemetic medication","rescue antyhypotensive medication",{"intervention":1320,"totalTrials":78,"cells":1325},{"EARLY_PHASE1":1326,"PHASE1":1328,"PHASE2":1330,"PHASE3":1332,"PHASE4":1334,"NA":1336},{"trials":1327,"activeCount":82},[],{"trials":1329,"activeCount":82},[],{"trials":1331,"activeCount":82},[],{"trials":1333,"activeCount":82},[],{"trials":1335,"activeCount":82},[],{"trials":1337,"activeCount":82},[1338],{"nctId":1312,"briefTitle":1313,"status":381,"phases":1339,"primaryCompletion":1315,"completion":1315,"start":1316,"enrollment":862,"conditions":1340,"interventions":1341},[75],[1318],[1297,1320,1321,1322,1323,1323],{"intervention":1321,"totalTrials":78,"cells":1343},{"EARLY_PHASE1":1344,"PHASE1":1346,"PHASE2":1348,"PHASE3":1350,"PHASE4":1352,"NA":1354},{"trials":1345,"activeCount":82},[],{"trials":1347,"activeCount":82},[],{"trials":1349,"activeCount":82},[],{"trials":1351,"activeCount":82},[],{"trials":1353,"activeCount":82},[],{"trials":1355,"activeCount":82},[1356],{"nctId":1312,"briefTitle":1313,"status":381,"phases":1357,"primaryCompletion":1315,"completion":1315,"start":1316,"enrollment":862,"conditions":1358,"interventions":1359},[75],[1318],[1297,1320,1321,1322,1323,1323],{"intervention":1322,"totalTrials":78,"cells":1361},{"EARLY_PHASE1":1362,"PHASE1":1364,"PHASE2":1366,"PHASE3":1368,"PHASE4":1370,"NA":1372},{"trials":1363,"activeCount":82},[],{"trials":1365,"activeCount":82},[],{"trials":1367,"activeCount":82},[],{"trials":1369,"activeCount":82},[],{"trials":1371,"activeCount":82},[],{"trials":1373,"activeCount":82},[1374],{"nctId":1312,"briefTitle":1313,"status":381,"phases":1375,"primaryCompletion":1315,"completion":1315,"start":1316,"enrollment":862,"conditions":1376,"interventions":1377},[75],[1318],[1297,1320,1321,1322,1323,1323],{"intervention":1323,"totalTrials":78,"cells":1379},{"EARLY_PHASE1":1380,"PHASE1":1382,"PHASE2":1384,"PHASE3":1386,"PHASE4":1388,"NA":1390},{"trials":1381,"activeCount":82},[],{"trials":1383,"activeCount":82},[],{"trials":1385,"activeCount":82},[],{"trials":1387,"activeCount":82},[],{"trials":1389,"activeCount":82},[],{"trials":1391,"activeCount":82},[1392],{"nctId":1312,"briefTitle":1313,"status":381,"phases":1393,"primaryCompletion":1315,"completion":1315,"start":1316,"enrollment":862,"conditions":1394,"interventions":1395},[75],[1318],[1297,1320,1321,1322,1323,1323],{"intervention":912,"totalTrials":78,"cells":1397},{"EARLY_PHASE1":1398,"PHASE1":1400,"PHASE2":1402,"PHASE3":1404,"PHASE4":1406,"NA":1408},{"trials":1399,"activeCount":82},[],{"trials":1401,"activeCount":82},[],{"trials":1403,"activeCount":82},[],{"trials":1405,"activeCount":82},[],{"trials":1407,"activeCount":82},[],{"trials":1409,"activeCount":82},[1410],{"nctId":902,"briefTitle":903,"status":417,"phases":1411,"primaryCompletion":905,"completion":906,"start":860,"enrollment":907,"conditions":1412,"interventions":1413},[75],[30,32,909],[874,911,912],{"intervention":1415,"totalTrials":78,"cells":1416},"Chlorhexidine Gluconate",{"EARLY_PHASE1":1417,"PHASE1":1419,"PHASE2":1421,"PHASE3":1423,"PHASE4":1425,"NA":1427},{"trials":1418,"activeCount":82},[],{"trials":1420,"activeCount":82},[],{"trials":1422,"activeCount":82},[],{"trials":1424,"activeCount":82},[],{"trials":1426,"activeCount":82},[],{"trials":1428,"activeCount":82},[1429],{"nctId":1430,"briefTitle":1431,"status":417,"phases":1432,"primaryCompletion":1049,"completion":1049,"start":604,"enrollment":1433,"conditions":1434,"interventions":1436},"NCT06531720","Comparison of the Effects of Oral Ulceration Healing in Patients Wearing a Removable Denture",[75],27,[1435],"Oral Mucosa; Ulcer",[1415,1437],"Choline Salicylate 8.7 % Oral Gel",{"intervention":1437,"totalTrials":78,"cells":1439},{"EARLY_PHASE1":1440,"PHASE1":1442,"PHASE2":1444,"PHASE3":1446,"PHASE4":1448,"NA":1450},{"trials":1441,"activeCount":82},[],{"trials":1443,"activeCount":82},[],{"trials":1445,"activeCount":82},[],{"trials":1447,"activeCount":82},[],{"trials":1449,"activeCount":82},[],{"trials":1451,"activeCount":82},[1452],{"nctId":1430,"briefTitle":1431,"status":417,"phases":1453,"primaryCompletion":1049,"completion":1049,"start":604,"enrollment":1433,"conditions":1454,"interventions":1455},[75],[1435],[1415,1437],{"intervention":922,"totalTrials":78,"cells":1457},{"EARLY_PHASE1":1458,"PHASE1":1460,"PHASE2":1462,"PHASE3":1464,"PHASE4":1466,"NA":1468},{"trials":1459,"activeCount":82},[],{"trials":1461,"activeCount":82},[],{"trials":1463,"activeCount":82},[],{"trials":1465,"activeCount":82},[],{"trials":1467,"activeCount":82},[],{"trials":1469,"activeCount":82},[1470],{"nctId":914,"briefTitle":915,"status":417,"phases":1471,"primaryCompletion":917,"completion":918,"start":893,"enrollment":919,"conditions":1472,"interventions":1473},[75],[30,32,909],[874,922,923,924],{"intervention":924,"totalTrials":78,"cells":1475},{"EARLY_PHASE1":1476,"PHASE1":1478,"PHASE2":1480,"PHASE3":1482,"PHASE4":1484,"NA":1486},{"trials":1477,"activeCount":82},[],{"trials":1479,"activeCount":82},[],{"trials":1481,"activeCount":82},[],{"trials":1483,"activeCount":82},[],{"trials":1485,"activeCount":82},[],{"trials":1487,"activeCount":82},[1488],{"nctId":914,"briefTitle":915,"status":417,"phases":1489,"primaryCompletion":917,"completion":918,"start":893,"enrollment":919,"conditions":1490,"interventions":1491},[75],[30,32,909],[874,922,923,924]]